Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Metyrapone
Cat. No.:
OB0225LY-0439
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by HPLC.
Size:
Product Overview
Description:
Metyrapone is a widely used drug in endocrine research that inhibits cortisol synthesis and thus regulates glucocorticoid metabolism.
Synonym:
NSC-25265; Su-4885; 54-36-4; 2-Methyl-1,2-di-3-pyridyl-1-propanone; Metopiron; Methapyrapone; Methopirapone; Methopyrinine; Methopyrone; Metopyrone; Metyrapon; Methbipyranone; Mepyrapone; Metroprione; 1-Propanone, 1,2-di-3-pyridyl-2-methyl-; 2-methyl-1,2-bis(pyridin-3-yl)propan-1-one
CAS No.:
54-36-4
Compound CID:
4174
Formula:
C14H14N2O
Formula Weight:
226.27
Specification
Relative Density:
1.0852 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Metyrapone can be used in neuroendocrinology research or play an important role in stress response research.
Library Information
Targets:
Cytochrome P450 enzymes; Dehydrogenases
Receptors:
11β-HSD1; Camphor 5-monooxygenase; Cytochrome P450
Pathways:
Autophagy; Metabolism
Plate Number:
AOCL-6
Plate Location:
f6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
18.33 mg/mL; 81.02 mM
ALogP:
1.847
HBA_Count:
3
HBD_Count:
0
Rotatable Bond:
3
